Calmare Therapeutics Inc. Stock Price - CTTC

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
Ultimate Trader (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Calmare Therapeutics Inc. CTTC Other OTC Common Stock Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  0.0781 50.71% 0.2321 0.2374 0.111504 0.1277 0.154 15:59:53
Bid Price Ask Price Spread Spread % News
0.09 0.2321 0.1421 61.22% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
11 31,400 $ 0.152656 $ 4,793 6,334 0.0111 - 0.2374
Last Trade Time Type Quantity Stock Price Currency
15:48:35 500 $ 0.2321 USD

Calmare Therapeutics Inc. Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 7.05M 30.38M $ -3.83M - -1.84 22.36M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Calmare Therapeutics Inc. News

Latest CTTC Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CTTC Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week0.145750.23740.1115040.140050031k5k0.0863559.25%
1 Month0.10490.23740.095350.121850031k7k0.1272121.26%
3 Months0.04750.23740.04750.104415054k9k0.1846388.63%
6 Months0.0550.23740.01110.072810080k15k0.1771322.00%
1 Year0.13980.23740.01110.088614138k13k0.092366.02%
3 Years0.219450.23740.01110.12502309k17k0.012655.76%
5 Years0.330.490.01110.18602925k23k-0.0979-29.67%

Calmare Therapeutics Inc. Description

Calmare Therapeutics Incorporated, the Calmare Pain Mitigation Therapy company, researches, develops and commercializes chronic, neuropathic pain and wound affliction devices. Our flagship medical device - the Calmare Pain Therapy Device (the Calmare Device) is the world's only non-invasive and non-addictive modality that can successfully treat chronic, neuropathic pain. The Company holds a U.S. Food & Drug Administration 510k clearance designation on its flagship device, which grants it the exclusive right to sell, market, research and develop the medical device in the United States. Calmare Devices are commercially sold to medical practices throughout the world. They are also found in U.S. military hospitals, clinics and on installations via CTI's General Services Administration (GSA) military contract (V797P-4300B).

Your Recent History
Calmare Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.